WebFeb 13, 2024 · Note: Biological Dynamics's revenues are gauged from an analysis of company filings. Investor Activity ... These investors may include private investors, venture capital firms, or other investment vehicles. Date Investors Percent Raised Target Size; November 1, 2024: 1: 40%: $30 MM: Complete list of funding rounds and total amounts … Web1 day ago · 10.1 Future Forecast of the Global Biological Chip Market from 2024-2031 Segment by Region 10.2 Global Biological Chip Production and Growth Rate Forecast by Type (2024-2031) 10.3 Global ...
Biological Dynamics Raises $26.8M in Private Financing
WebNov 9, 2015 · November 9, 2015. Molecular diagnostics company Biological Dynamics has completed a $26.8 million financing, which consists of Series C investment and … WebDec 22, 2024 · Biological Dynamics announced it has named Kevin Han as its new Chief Financial Officer, bringing a depth of expertise in capital markets and investor relations and a breadth of healthcare industry knowledge. ... investment management, and investor relations, specifically focused on the life science tools, diagnostics, and medical … open corporates mi
Biological Dynamics Appoints Industry Veteran Peter Wulff as …
Web3 hours ago · Why the Pentagon should “surge” investments in pathogen early warning systems. By Christine ... Doing so is an increasing concern given real-world dynamics—including the threat that Russia might use biological or chemical weapons in Ukraine. Indeed, the past year of war drives home the need for deploying the tools that … WebDec 1, 2024 · SAN DIEGO, Dec. 1, 2024 /PRNewswire/ -- Biological Dynamics, a company developing its exosome-isolation ExoVerita™ platform for early disease diagnostics, announced today it has received IRB approval and will soon begin to enroll patients in its ExoLuminate™ clinical study to validate its pancreatic ductal … WebRevenue: $1 to $5 million (USD) Competitors: Unknown. Biological Dynamics, Inc. is a biotechnology company committed to improving global health outcomes by detecting disease in its earliest stages. Our proprietary Verita™ platform simplifies access to biomarkers, nanoparticles, and nucleic acids, enabling differentiated multiomic ... open corporate bank account in hong kong